+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Japan In Vitro Diagnostics (IVD) Market, by Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges

  • ID: 5024110
  • Report
  • May 2020
  • Region: Japan
  • 144 Pages
  • Renub Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • Biomerieux
  • Danaher Corporation
  • Roche Diagnostics

As most of the industry growth rate in Japan is hit due to COVID-19, but on the contrary, Japan In-Vitro Diagnostics Market is expected to put an exceptional higher growth rate in 2020 compared to its past years (read the report for Coronavirus impact on IVD industry of Japan). According to the research report, Japan In-vitro Diagnostic Market is projected to reach US$ 4.43 Billion by 2026.

In-vitro Diagnostics falls under the medical devices segment, which is used by disposable & consumable, and it is also used in many different, different types of medical tones to find multiple bio-samples. In recent years, several developments have happened in the field of In-vitro diagnostics like conventional diagnostics to new generation gene diagnostics. This has become possible with the advent of new technologies, such as genetic testing, chain reaction (PCR), next-generation sequencing (NGS), and molecular diagnostics.

Factors driving the IVD Market in Japan

In Japan, a quarter of its population age 65 years & above and also has the highest proportion of the aging population across the globe. The main problem faced by the Japanese government in recent years is the rise in the number of an aging population, as the cases of aging diseases are multiplying. Accordingly, the Japanese government has given priority to deal with the aging population, and the government is expected to devote an expanded health budget to aging by 2025. This will boost the future of the Japanese In-Vitro Diagnostics Industry by rising prevalence and increased public expenditure.

Apart from that enhanced diagnostic technology, people's awareness and the subsequent growth in the prevalence of chronic and infectious diseases, a rise in the number of private hospitals, and independent testing laboratories are also some of the other factors that contribute to its market growth. Japan's clinical laboratory markets represent one of the largest and fastest-growing markets among the top ten IVD nation markets in the Asia Pacific regions.

The report titled “Japan In Vitro Diagnostics (IVD) Market, by Diagnostics (Tumor Marker, Urine & Feces, Clinical Chemistry, Hematology, Self Monitoring of Blood Glucose (SMBG), Immunology, Infectious disease, Microbiology, Pathology, and Genetic Testing) Companies (Abbott Laboratories, Danaher Corporation, Biomerieux, Roche Diagnostics, and Becton Dickinson), Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges” provides a complete analysis of Japan In Vitro Diagnostics (IVD) Market.

All the 11 Segments analysis of Japan In-Vitro Diagnostics Market

In this report, we have provided a complete analysis of 11 segments of the Japan In-vitro Diagnostic market. These segments are as follows Clinical Chemistry, Urine & Feces, Hematology, Tumor Marker, Self Monitoring Blood Glucose (SMBG), Immunology, Infectious disease, Microbiology, Pathology, Genetic Testing, and Others. In these In vitro diagnostics segments, we have done a comprehensive analysis of each segment due to COVID-19 along with separate growth factors for each segment.

Good Reimbursement Policy is expected ill further boost the Market of Japan In Vitro Diagnostics Market

Our report describes the scope and breadth of the reimbursement policies along with the full context. It also provides specific guidance and structure about how it operates and how Japanese authorities implement reimbursement policies. It describes how medical devices are categorized in Japan and which class In vitro diagnostic suits. It includes all medical manufacturers that have been in Japan for the past five years applying for reimbursement approval.

Porter's Five Forces Analysis

This research report provides a compressive study of all the 5 Porter's forces and their significant effect on Japan IVD industry.

By Segment:


  • Urine & Faces Diagnostics
  • Hematology
  • Clinical Chemistry
  • Self-Blood Glucose Monitoring
  • Tumor Marker
  • Immunology
  • Infectious Testing
  • Microbiology
  • Pathology
  • Genetic Testing
  • Others

All the companies given in the report has been studied from two points


  • Recent Developments
  • Sales Analysis

Company Analysis:


  • Abbott Laboratories
  • Danaher Corporation
  • Biomerieux
  • Roche Diagnostics
  • Becton Dickinson
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • Biomerieux
  • Danaher Corporation
  • Roche Diagnostics

1. Introduction2. Research Methodology3. Executive Summery
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities
5. Porter's Five Forces Analysis
5.1 Threat of New Entry
5.2 The Bargaining Power of Buyer
5.3 Threat of Substitution
5.4 The Bargaining Power of Supplier
5.5 Competitive Rivalry
6. Reimbursement Policy7. Japan in Vitro Diagnostics Market
8. Market Share - Japan in Vitro Diagnostics
8.1 By Segment
9. Segments - Japan in Vitro Diagnostics Market
9.1 Urine & Faces Diagnostics
9.2 Hematology
9.3 Clinical Chemistry
9.4 Self-Blood Glucose Monitoring
9.5 Tumor Marker
9.6 Immunology
9.7 Infectious Testing
9.8 Microbiology
9.9 Pathology
9.10 Genetic Testing
9.11 Others
10. Company Analysis
10.1 Abbott Laboratories
10.1.1 Overview
10.1.2 Recent Development/Strategy
10.1.3 Sales
10.2 Danaher Corporation
10.2.1 Overview
10.2.2 Recent Development/Strategy
10.2.3 Sales
10.3 Biomerieux
10.3.1 Overview
10.3.2 Recent Development/Strategy
10.3.3 Sales
10.4 Roche Diagnostics
10.4.1 Overview
10.4.2 Recent Development/Strategy
10.4.3 Sales
10.5 Becton
10.5.1 Overview
10.5.2 Recent Development/Strategy
10.5.3 Sales
List of Figures:
Figure-01: Japan- In-vitro Diagnostic Market size (Million US$), 2018 & 2024
Figure-02: Japan- In-vitro Diagnostic Top Two Rapid Growing Segment 2020 - 2026
Figure-03: Japan- In-vitro Diagnostic Largest Market Share, Immunology (Percent), 2019 -2026
Figure-04: Japan- Age-related disease type (Percentage), 2005 - 2016
Figure-05: Japan - Healthcare expenditure GDP( Percentage) 2018-2030
Figure-06: Japna - Healthcare expenditure market (Billion US$), 2005 - 2025
Figure-07: Japan- Government Healthcare Spending for 75 and older Population ( Billion US$), 2015 - 2025
Figure-08: Japan - In-vitro Diagnostics Market (Million US$), 2012 - 2019
Figure-09: Japan - Forecast for In-vitro Diagnostics Market (Million US$), 2020 - 2026
Figure-10: Japan- Urine & Faces Diagnostics Market (Million US$), 2012 - 2019
Figure-11: Japan- Forecast for Urine & Faces Diagnostics Market (Million US$), 2020 - 2026
Figure-12: Japan- Hematology Market (Million US$), 2012 - 2019
Figure-13: Japan- Forecast for Hematology Market (Million US$), 2020 - 2026
Figure-14: Japan- Clinical Chemistry Market (Million US$), 2012 - 2019
Figure-15: Japan- Forecast for Clinical Chemistry Market (Million US$), 2020 - 2026
Figure-16: Japan- SMBG Market (Million US$), 2012 - 2019
Figure-17: Japan- Forecast for SMBG Market (Million US$), 2020 - 2026
Figure-18: Japan- Tumor Marker Market (Million US$), 2012 - 2019
Figure-19: Japan- Forecast for Tumor Marker Market (Million US$), 2020 - 2026
Figure-20: Japan- Immunology Market (Million US$), 2012 - 2019
Figure-21: Japan- Forecast for Immunology Market (Million US$), 2020 - 2026
Figure-22: Japan- Infectious Disease Market (Million US$), 2012 - 2019
Figure-23: Japan- Forecast for Infectious Disease Market (Million US$), 2020 - 2026
Figure-24: Japan- Microbiology Testing Market (Million US$), 2012 - 2019
Figure-25: Japan- Forecast for Microbiology Testing Market (Million US$), 2020 - 2026
Figure-26: Japan - Pathology Market (Million US$), 2012 - 2019
Figure-27: Japan- Forecast for Pathology Market (Million US$), 2020 - 2026
Figure-28: Japan - Genetic Testing Market (Million US$), 2012 - 2019
Figure-29: Japan - Forecast for Genetic Testing Market (Million US$), 2020 - 2026
Figure-30: Japan- Others Segment Market (Million US$), 2012 - 2019
Figure-31: Japan - Forecast for Others Market (Million US$), 2020 - 2026
Figure-32: Abbott Laboratories - Global Diagnostic Sales (Million US$), 2015 - 2019
Figure-33: Abbott Laboratories - Global Forecast for Diagnostic Sales (Million US$), 2020 - 2026
Figure-34: Danaher Corporation - Global Diagnostic Sales (Million US$), 2015 - 2019
Figure-35: Danaher Corporation - Global Forecast for Diagnostic Sales (Million US$), 2020 - 2026
Figure-36: Biomérieux- Global Diagnostic Sales (Million US$), 2015 - 2019
Figure-37: Biomérieux - Global Forecast for Diagnostic Sales (Million US$), 2020 - 2026
Figure-38: Roche Diagnostics - Global Diagnostics Division sales (Million US$), 2015 - 2019
Figure-39: Roche Diagnostics - Global Forecast for Diagnostics Division sales (Million US$), 2020 - 2026
Figure-40: Becton - Global Diagnostics System sales (Million US$), 2015 - 2019
Figure-41: Becton - Global Forecast for Diagnostics System sales (Million US$), 2020 - 2026
List of Tables:
Table-1: Growth Drivers % change 2005 - 2016
Table-2: Japan - Medical device & equipments reembursement policy
Table-3: Japan - In-vitro Diagnostics by Segment Market Share (Percent), 2012 - 2019
Table-4: Japan - Forecast for In-vitro Diagnostics by Segment Market Share (Percent), 2020 - 2026
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Danaher Corporation
  • Biomerieux
  • Roche Diagnostics
  • Becton Dickinson
Note: Product cover images may vary from those shown

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...